Target intelligence / Profile preview

Dolichyl-phosphate mannosyltransferase subunit 1, catalytic (DPM1)

Target
DPM1
Molecular classification
Enzyme, Glycosyltransferase
01

Overview

Dolichyl-phosphate mannosyltransferase subunit 1, catalytic (DPM1), is the catalytic component of the dolichyl-phosphate mannose (DPM) synthase enzyme complex, which is responsible for transferring mannose from GDP-mannose to dolichol monophosphate to produce dolichol-phosphate mannose (Dol-P-Man) on the cytosolic side of the endoplasmic reticulum (ER)[1][5][6]. Dol-P-Man serves as a crucial donor for mannosyl residues in several glycosylation processes, including N-glycosylation, GPI-anchor biosynthesis, and O-mannosylation of proteins. DPM1 is essential for normal cell function and development; genetic deficiencies cause congenital disorders of glycosylation. DPM1 lacks a transmembrane domain and is regulated by additional subunits DPM2 and DPM3 that assist in ER localization and complex stability[3][5].

Other names
DPM1Dolichyl-phosphate beta-D-mannosyltransferase subunit 1Dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunitDolichol-phosphate mannosyltransferase subunit 1Dolichol-phosphate mannose synthase subunit 1CDGIEMPDSMannose-P-dolichol synthase subunit 1DPM synthase subunit 1MPD synthase subunit 1EC 2.4.1.83[5][9]
02

Biological functions

Protein glycosylationN-glycosylationGlycosylphosphatidylinositol (GPI) anchor biosynthesisO-mannosylation of proteins[1][5][6]
03

Disease associations

Congenital disorders of glycosylation (specifically CDG type Ie)Developmental and epileptic encephalopathyMuscular dystrophy-dystroglycanopathyCancer (altered expression noted in some cancers)[5][6]
04

Safety considerations

Disruption leads to substantial defects in protein glycosylation, broad effects on cellular function, and severe congenital disease if mutatedComplete inhibition would likely be toxic, given DPM1 is essential for viability and protein processing[1][5][6]
05

Biomarkers

Mutations in DPM1 serve as biomarkers for certain congenital disorders of glycosylation[5][6]

Beyond the preview

Go deeper on Dolichyl-phosphate mannosyltransferase subunit 1, catalytic (DPM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dolichyl-phosphate mannosyltransferase subunit 1, catalytic (DPM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call